Logo for the American Society of Clinical Oncology
Logo for the Association of Community Cancer Centers

The American Society of Clinical Oncology (ASCO) and Association of Community Cancer Centers (ACCC) joined forces to ensure that cancer clinical trials better reflect the diversity of people with cancer.

After receiving ideas from the oncology community, and pilot testing resources, ASCO and ACCC recently released influential, free, and practical resources for research sites to help make changes in cancer clinical trials.

The ASCO-ACCC Equity, Diversity, and Inclusion Research Site Self-Assessment

Three resources to diversify cancer clinical trials.

The ASCO-ACCC Equity, Diversity, and Inclusion Research Site Self-Assessment (Site Self-Assessment) is an online tool that helps research teams identify potential opportunities to improve equity, diversity, and inclusion (EDI) in clinical trials while doing an internal review of existing policies, programs, and procedures. The Site Self-Assessment is a quality improvement tool framed around the clinical trial enrollment continuum and includes domains related to patient access to the site, screening patients for clinical trials, offering patients clinical trials, and participation and retention in trials. Completion of the assessment provides sites strategies for improvement such as diversifying the workforce, developing sustainable community partnerships, implicit bias training, and routinely collecting screening and enrollment data to assess and address disparities. 

Access the Site Self-Assessment now.

The Just ASK™ Increasing Diversity in Cancer Clinical Research: An ACCC-ASCO Training Program

The Just ASK™ Training Program, adapted from a course developed at Duke University, is an online implicit bias training program intended for all members of the research team. It consists of five interactive modules—which can be completed independently in about in 60-90 minutes—that present the broader context of structural and systemic racism, the role of implicit bias in clinical trial selection, vignettes with real-world examples of implicit bias, and guidance for mitigating disparities in cancer research settings. A companion Facilitation Guide is also available to help sites continue the conversation with the larger research team after taking the training.

Access the Just ASK ™ Training Program now.

Recommendations to Diversify Clinical Trials

Research Statement on Diversifying Clinical Trial

ASCO and ACCC jointly published a research statement in the Journal of Clinical Oncology: “Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.” This research statement details specific actions to engage the entire cancer clinical trial ecosystem in expanding the participation of underrepresented individuals in research that advances progress against cancer. Review the overview of the recommendations and read the full research statement

Additional Strategies and Resources

An annotated reference list of detailed strategies and resources is also available online. This list is intended to provide examples of strategies for research sites to increase EDI in cancer clinical trials. It may also help stimulate research to establish evidence-based strategies that demonstrate increased participation of patients historically underrepresented in clinical trials.

    Initial Work of the Collaboration

    ASCO and ACCC launched this initiative in July 2020 with a request for ideas from the research community regarding novel strategies and practical solutions to increase EDI in clinical trials. Based on the responses, the Site Self-Assessment and an Implicit Bias Training Program were developed and tested by seventy-five research sites from across the United StatesSee the full list of sites that participatedFindings from the pilot project will be submitted for publication shortly.

    The collaboration is led by ASCO Board Chair Lori J. Pierce, MD, FASTRO, FASCO, and ACCC Immediate Past President Randall A. Oyer, MD. EDI experts, including a Steering Group and a Patient Partners Advisory Group, have provided invaluable guidance and expertise for this initiative.

      Announcements About the Initiative

      Thank You to Our Donors:

      The ASCO-ACCC Collaboration to Increase Racial and Ethnic Diversity in Clinical Trials is funded through Conquer Cancer, the ASCO Foundation, by generous donors of the Equity, Diversity, and Inclusion Initiative.